Shareholders Equity: The sum of preferred and common equity items.
Context Therapeutics Inc. (CNTX) had Shareholders Equity of $60.47M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-13.03M |
|
-- |
|
-- |
|
$13.80M |
|
$-13.80M |
|
$0.78M |
|
$-13.03M |
|
$-13.03M |
|
$-13.03M |
|
$-13.03M |
|
$-13.03M |
|
$-13.03M |
|
$-13.80M |
|
$-13.80M |
|
95.19M |
|
95.19M |
|
$-0.14 |
|
$-0.14 |
|
| Balance Sheet Financials | |
$68.35M |
|
$0.03M |
|
$0.14M |
|
$68.49M |
|
$8.02M |
|
-- |
|
-- |
|
$8.02M |
|
$60.47M |
|
$60.47M |
|
|
Shareholders Equity |
$60.47M |
91.88M |
|
| Cash Flow Statement Financials | |
$-26.39M |
|
$-2.03M |
|
$-0.02M |
|
$94.43M |
|
$66.00M |
|
$-28.43M |
|
$1.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-26.42M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.54% |
|
-21.54% |
|
-19.02% |
|
-21.54% |
|
$0.66 |
|
$-0.28 |
|
$-0.28 |
|